Finland· FI-REL-REL37251

Candesarstad

A candesartan product containing candesartan cilexetil, registered in Finland by STADA Arzneimittel AG. The same ATC class is registered in 16 of our 19 countries.

ATC C09CA06

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedCandesarstadATCC09CA06REGISTER NO.FI-REL-REL37251PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Candesartan is registered in 16 of 19 countries.

Countries holding a registration under ATC C09CA06 (candesartan), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 9 of them publish a price we can compare per daily dose

Candesartan · ATC C09CA06

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of candesartan costs, country by country.

Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.15 in Italy to $0.36 in Switzerland — a ×2.3 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Candesartan · price per daily dose (8 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.36
  • ES Spain$0.21
  • IT Italy$0.15
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Candesartan cilexetil
Manufacturer
STADA Arzneimittel AG
Country
Finland (FI)
ATC code
C09CA06
ATC class
Candesartan
Defined daily dose
8 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    488012
    98
    EUR 3.3

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for candesartan.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Candesartan · interactions on record

81 records

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Candesartan in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All candesartan products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Atacand, Blopress
  • Belgium · Atacand, Candesartan Eg
  • Bulgaria · Атаканд, Кандекон
  • Cyprus · Atacand, Candepress
  • Czechia · Canocord, Carzap
  • Germany · Atacand, Atacand Protect
  • Denmark · Atacand, Candemox
  • Estonia · Atacand, Canocord
  • Spain · Atacand, Blopress
  • France · Atacand, Candesartan Arrow
  • United Kingdom (Northern Ireland) · Amias, Atacand
  • Greece · Atacand, Fyronexe
  • Croatia · Kandepres, Kandepres 16
  • Hungary · Karbis
  • Ireland · Atacand, Blopress
  • Iceland · Candesartan Stada, Candpress
  • Italy · Blopress, Candesartan Alter
  • Lithuania · Canocord, Carzan
  • Luxembourg · Atacand, Candesartan Eg
  • Latvia · Canocord, Carzan
  • Malta · Candesartan, Candesartan Cilexetil Aurobindo Pharma (Malta)
  • Netherlands · Atacand, Candesartan Cilexetil Aurobindo
  • Norway · Atacand, Candesartan Krka
  • Poland · Atacand, Candepres
  • Portugal · Atacand, Blopress
  • Romania · Atacand, Candesartan
  • Sweden · Atacand, Canderion
  • Slovenia · Atacand, Candea
  • Slovakia · Atacand, Candesartan Ratiopharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fea59d62-8a46-4f6c-9ee5-975e256a2f6e
GET /v1/drugs/fea59d62-8a46-4f6c-9ee5-975e256a2f6e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "8",
  "form": "tabletti",
  "route": "Suun kautta",
  "ddd_unit": "mg",
  "strength": "8 mg",
  "atc_label": "kandesartaani",
  "ma_number": "28620",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL37251",
  "authorised_at": "2012-01-30"
}

See everything about candesartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.